Skip to main content
. 2018 Sep 23;2018:9430953. doi: 10.1155/2018/9430953

Figure 2.

Figure 2

Summary schematic of the effects of cannabis use by HCV infected individuals and liver disease associated parameters. Our observations suggest that cannabis use by HCV infected individuals is associated with significant reduction in adverse progressive disease associated pathologies. Further, cannabis users had an overall lower cost of disease management compared to noncannabis users. Schematic illustrations made use of some motifolio templates (http://www.motifolio.com/).